These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 17941081

  • 1. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, Condorelli G, Ellingsen O.
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ.
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [Abstract] [Full Text] [Related]

  • 3. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F, Ghosh-Choudhury N, Mahimainathan L, Venkatesan B, Feliers D, Riley DJ, Kasinath BS, Choudhury GG.
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [Abstract] [Full Text] [Related]

  • 4. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX, Yang X, Sreejayan N, Ren J.
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
    McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S.
    Circulation; 2004 Jun 22; 109(24):3050-5. PubMed ID: 15184287
    [Abstract] [Full Text] [Related]

  • 6. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A, Tee AR, Taylor PM, Proud CG.
    Biochem J; 2003 Jun 01; 372(Pt 2):555-66. PubMed ID: 12611592
    [Abstract] [Full Text] [Related]

  • 7. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ.
    Nat Cell Biol; 2001 Nov 01; 3(11):1009-13. PubMed ID: 11715022
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM, Ma YT, Yang YN, Liu F, Chen BD, Han W, Zhang JF, Gao XM.
    Clin Exp Pharmacol Physiol; 2009 Nov 01; 36(11):1054-61. PubMed ID: 19566828
    [Abstract] [Full Text] [Related]

  • 9. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.
    Chen JK, Chen J, Neilson EG, Harris RC.
    J Am Soc Nephrol; 2005 May 01; 16(5):1384-91. PubMed ID: 15788477
    [Abstract] [Full Text] [Related]

  • 10. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O, Almazan G.
    J Neurochem; 2009 Jun 01; 109(5):1440-51. PubMed ID: 19453943
    [Abstract] [Full Text] [Related]

  • 11. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 12. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.
    Sunavala-Dossabhoy G, Fowler M, De Benedetti A.
    BMC Mol Biol; 2004 Apr 07; 5():1. PubMed ID: 15070431
    [Abstract] [Full Text] [Related]

  • 13. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
    Altamirano F, Oyarce C, Silva P, Toyos M, Wilson C, Lavandero S, Uhlén P, Estrada M.
    J Endocrinol; 2009 Aug 07; 202(2):299-307. PubMed ID: 19474060
    [Abstract] [Full Text] [Related]

  • 14. Rheb activation of mTOR and S6K1 signaling.
    Hanrahan J, Blenis J.
    Methods Enzymol; 2006 Aug 07; 407():542-55. PubMed ID: 16757352
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA, O'Connell TD, Gerdes AM.
    Endocrinology; 2007 Jul 07; 148(7):3477-84. PubMed ID: 17395699
    [Abstract] [Full Text] [Related]

  • 16. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC, Glynn EL, Lujan HL, Fry CS, DiCarlo SE, Rasmussen BB.
    J Appl Physiol (1985); 2008 Jan 07; 104(1):27-33. PubMed ID: 17885021
    [Abstract] [Full Text] [Related]

  • 17. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD.
    Nat Cell Biol; 2001 Nov 07; 3(11):1014-9. PubMed ID: 11715023
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
    Wan X, Mendoza A, Khanna C, Helman LJ.
    Cancer Res; 2005 Mar 15; 65(6):2406-11. PubMed ID: 15781656
    [Abstract] [Full Text] [Related]

  • 19. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
    Clemente CF, Xavier-Neto J, Dalla Costa AP, Consonni SR, Antunes JE, Rocco SA, Pereira MB, Judice CC, Strauss B, Joazeiro PP, Matos-Souza JR, Franchini KG.
    J Mol Cell Cardiol; 2012 Feb 15; 52(2):493-501. PubMed ID: 22056317
    [Abstract] [Full Text] [Related]

  • 20. Maximal lengthening contractions increase p70 S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply.
    Eliasson J, Elfegoun T, Nilsson J, Köhnke R, Ekblom B, Blomstrand E.
    Am J Physiol Endocrinol Metab; 2006 Dec 15; 291(6):E1197-205. PubMed ID: 16835402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.